15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English alg-000184在美肝会数据
查看: 172|回复: 2
go

alg-000184在美肝会数据 [复制链接]

Rank: 10Rank: 10Rank: 10

现金
20677 元 
精华
帖子
12801 
注册时间
2013-12-29 
最后登录
2024-11-21 
1
发表于 2023-11-10 21:43 |只看该作者 |倒序浏览 |打印

Rank: 10Rank: 10Rank: 10

现金
20677 元 
精华
帖子
12801 
注册时间
2013-12-29 
最后登录
2024-11-21 
2
发表于 2023-11-10 22:01 |只看该作者
Mean HBsAg, HBeAg, and HBcrAg reductions of 1.2 log10 IU/mL, 1.7 log10 PEI U/L and 2.0 log10 U/mL, respectively, at
Week 48. These reductions were dose-dependent, independent of co-administration of ETV, and suggest that ALG-000184
may reduce cccDNA levels via both the 1st and 2nd mechanisms of action of CAM-E drugs
1.
Greater mean DNA reductions were observed for ALG-000184 + ETV vs. ETV monotherapy after treatment for 12 weeks;
maximum mean DNA reductions of 6.8 log10 IU/mL for the ALG-000184 + ETV combination were observed at Week 48
2.
Mean DNA reductions were comparable for 300 mg ALG-000184 with or without ETV, indicating ETV did not further impact
DNA lowering. No viral DNA breakthroughs were observed in subjects receiving ALG-000184 monotherapy
3.
4. ALG-000184 with or without ETV was well tolerated with no safety signals identified

Rank: 10Rank: 10Rank: 10

现金
20677 元 
精华
帖子
12801 
注册时间
2013-12-29 
最后登录
2024-11-21 
3
发表于 2023-11-10 22:02 |只看该作者
平均HBsAg、HBeAg和HBcrAg分别降低1.2 log10 IU/mL、1.7 log10 PEI U/L和2.0 log10 U/mL 48周。这些减少是剂量依赖性的,独立于ETV的联合给药,表明ALG-000184 是否可以通过CAM-E药物的第一和第二种作用机制来降低cccDNA水平 1. 在治疗12周后,ALG-000184 + ETV与ETV单药相比,观察到更大的平均DNA减少; 在第48周观察到ALG-000184 + ETV组合的最大平均DNA减少量为6.8 log10 IU/mL 2. 300 m的平均DNA减少量相当
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-22 11:23 , Processed in 0.012602 second(s), 10 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.